Lianhe Chemical TechnologyLtd Crecimiento futuro
Future controles de criterios 3/6
Lianhe Chemical TechnologyLtd is forecast to grow earnings and revenue by 101.1% and 9.9% per annum respectively. EPS is expected to grow by 102.6% per annum. Return on equity is forecast to be 2.8% in 3 years.
Información clave
101.1%
Tasa de crecimiento de los beneficios
102.6%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Chemicals | 38.3% |
Tasa de crecimiento de los ingresos | 9.9% |
Rentabilidad financiera futura | 2.8% |
Cobertura de analistas | Low |
Última actualización | 19 Sep 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Little Excitement Around Lianhe Chemical Technology Co.,Ltd.'s (SZSE:002250) Revenues
Oct 24Is Lianhe Chemical TechnologyLtd (SZSE:002250) Using Debt In A Risky Way?
Sep 25Lianhe Chemical TechnologyLtd's (SZSE:002250) Dividend Will Be Reduced To CN¥0.02
Jul 12Why Investors Shouldn't Be Surprised By Lianhe Chemical Technology Co.,Ltd.'s (SZSE:002250) Low P/S
Jun 07Returns Are Gaining Momentum At Lianhe Chemical TechnologyLtd (SZSE:002250)
Feb 28Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 7,332 | 183 | N/A | 1,082 | 1 |
12/31/2025 | 6,745 | 209 | N/A | 1,256 | 2 |
12/31/2024 | 6,241 | 91 | N/A | 1,229 | 2 |
9/30/2024 | 5,783 | -357 | 408 | 1,147 | N/A |
6/30/2024 | 5,755 | -476 | 268 | 1,100 | N/A |
3/31/2024 | 5,950 | -507 | -286 | 849 | N/A |
12/31/2023 | 6,442 | -465 | 22 | 1,077 | N/A |
9/30/2023 | 6,982 | 279 | -251 | 933 | N/A |
6/30/2023 | 7,828 | 517 | -694 | 820 | N/A |
3/31/2023 | 8,130 | 667 | -1,141 | 406 | N/A |
12/31/2022 | 7,865 | 697 | -1,092 | 639 | N/A |
9/30/2022 | 7,749 | 380 | -605 | 931 | N/A |
6/30/2022 | 7,276 | 331 | -499 | 1,028 | N/A |
3/31/2022 | 6,851 | 306 | -608 | 1,016 | N/A |
12/31/2021 | 6,587 | 315 | -907 | 738 | N/A |
9/30/2021 | 6,097 | 166 | -1,342 | 544 | N/A |
6/30/2021 | 5,676 | 191 | -547 | 1,261 | N/A |
3/31/2021 | 5,528 | 231 | -183 | 1,448 | N/A |
12/31/2020 | 4,782 | 110 | -83 | 1,379 | N/A |
9/30/2020 | 4,407 | 73 | 35 | 1,397 | N/A |
6/30/2020 | 4,016 | 14 | -639 | 625 | N/A |
3/31/2020 | 3,703 | -45 | -152 | 1,005 | N/A |
12/31/2019 | 4,284 | 144 | -63 | 1,051 | N/A |
9/30/2019 | 4,809 | 349 | 273 | 1,235 | N/A |
6/30/2019 | 4,681 | 270 | 377 | 1,165 | N/A |
3/31/2019 | 4,385 | 129 | -56 | 673 | N/A |
12/31/2018 | 4,114 | 38 | -147 | 537 | N/A |
9/30/2018 | 3,808 | 16 | -429 | 227 | N/A |
6/30/2018 | 3,990 | 42 | N/A | 431 | N/A |
3/31/2018 | 4,260 | 183 | N/A | 517 | N/A |
12/31/2017 | 4,107 | 205 | N/A | 589 | N/A |
9/30/2017 | 3,717 | 195 | N/A | 530 | N/A |
6/30/2017 | 3,264 | 186 | N/A | 384 | N/A |
3/31/2017 | 3,021 | 240 | N/A | 427 | N/A |
12/31/2016 | 3,099 | 264 | N/A | 548 | N/A |
9/30/2016 | 3,319 | 445 | N/A | 574 | N/A |
6/30/2016 | 3,858 | 582 | N/A | 672 | N/A |
3/31/2016 | 4,029 | 593 | N/A | 722 | N/A |
12/31/2015 | 4,008 | 638 | N/A | 645 | N/A |
9/30/2015 | 4,065 | 616 | N/A | 696 | N/A |
6/30/2015 | 4,133 | 612 | N/A | 745 | N/A |
3/31/2015 | 4,040 | 582 | N/A | 619 | N/A |
12/31/2014 | 3,990 | 551 | N/A | 634 | N/A |
9/30/2014 | 3,852 | 522 | N/A | 653 | N/A |
6/30/2014 | 3,694 | 497 | N/A | 484 | N/A |
3/31/2014 | 3,616 | 475 | N/A | 473 | N/A |
12/31/2013 | 3,368 | 450 | N/A | 465 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: 002250 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Beneficios vs. Mercado: 002250 is forecast to become profitable over the next 3 years, which is considered above average market growth.
Beneficios de alto crecimiento: 002250 is expected to become profitable in the next 3 years.
Ingresos vs. Mercado: 002250's revenue (9.9% per year) is forecast to grow slower than the CN market (14% per year).
Ingresos de alto crecimiento: 002250's revenue (9.9% per year) is forecast to grow slower than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: 002250's Return on Equity is forecast to be low in 3 years time (2.8%).